Race Oncology (Race Oncology) Institutional Ownership : 0.03% (As of May. 01, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Race Oncology Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Race Oncology's institutional ownership is 0.03%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Race Oncology's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Race Oncology's Float Percentage Of Total Shares Outstanding is 0.00%.

Race Oncology Institutional Ownership Historical Data

The historical data trend for Race Oncology's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Race Oncology Institutional Ownership Chart

Race Oncology Historical Data

The historical data trend for Race Oncology can be seen below:

	2021-01-31	2021-02-28	2021-03-31	2021-04-30	2021-05-31	2021-06-30	2021-07-31	2021-08-31
Institutional Ownership	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.03

Race Oncology Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Race Oncology (Race Oncology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Race Oncology Ltd (OTCPK:RAONF) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

RAC:Australia

Address

1 Macquarie Place, Level 36, Gateway, Sydney, NSW, AUS, 2000

Website

https://www.raceoncology.com

Race Oncology Ltd is a specialty pharmaceutical company. It is engaged in the development and marketing of pharmaceutical drugs for the treatment of Cancer. Its product includes Bisantrene, a cancer chemotherapy drug. Its operating segments include research into oncology drugs, Zantrene and the manufacturing and distribution of the drug for clinical trials.

Race Oncology (Race Oncology) Headlines

From GuruFocus

Race Strategic Update August 2023

By PRNewswire • 08-08-2023

Race executes agreement with Ardena for GMP manufacturing of RC220

By PRNewswire • 07-12-2023

Race executes global license agreement with City of Hope to access FTO IP

By PRNewswire • 07-10-2023